Quantcast

Latest bioanalytics GmbH Stories

2011-05-09 05:30:00

BERLIN and BURLINGTON, Mass., May 9, 2011 /PRNewswire/ -- caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry (CCMS) platform technology for the analysis of small molecule - protein interactions, today announced a second closing of EUR 1 million ($1.4 M) to its Series B financing, increasing total equity for the round to EUR 5 million ($7.2 M). The capital increase was fully subscribed by LBBW Venture Capital...

2011-02-28 10:13:00

BERLIN, and BURLINGTON, Mass., Feb. 28, 2011 /PRNewswire/ -- caprotec bioanalytics GmbH announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry (CCMS) technology. CCMS offers a novel and direct way to investigate small molecule - protein interactions resulting in a significant functional reduction of proteome complexity. The core of the CCMS technology consists of...

2010-10-04 05:30:00

BERLIN and BURLINGTON, Mass., Oct. 4 /PRNewswire/ -- caprotec bioanalytics GmbH announced today the appointment of Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer of the company. Prior to joining caprotec, Prof. Metternich held senior leadership positions at Merck & Co., Schering AG and Novartis. "Professor Metternich is a prominent and respected leader in the global pharmaceutical industry," said caprotec founder and CEO Prof....

2010-09-30 05:00:00

BERLIN and BURLINGTON, Mass., Sept. 30 /PRNewswire/ -- caprotec bioanalytics GmbH announced today the commercial launch of three new caproKits(TM), enabling the discovery, identification and characterization of proteins for applications in functional proteomics and drug development. The three new kits are the Dasatinib caproKit, the C2 CAMP caproKit and the Biotin Capping Kit. Together, these new kits increase the number of commercially available caproKits to a total of 10. The company's...

2010-06-29 06:00:00

BERLIN and BURLINGTON, Mass., June 29 /PRNewswire/ -- caprotec bioanalytics GmbH announced today that it has successfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the binding characteristics and interaction of one undisclosed drug candidate with its human target proteins. To identify selectively interacting...

2010-05-13 15:55:00

BERLIN, and BURLINGTON, Mass., May 13 /PRNewswire/ -- caprotec bioanalytics GmbH today announced the closing of a EUR 4 million ($5.1M) Series B Financing Round with existing investors Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and well-known private investors. The proceeds will enable further development and marketing of the Company's proprietary CCMS (Capture Compound Mass Spectrometry) platform technology for analyzing complex protein mixtures. caprotec's CCMS...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related